Comparing epidemic tuberculosis in demographically distinct heterogeneous populations

Mathematical Biosciences

Volumn 180, Issue 1-2, 2002, Pages 161-185

  Murphy, Brian M ^a   Singer, Benjamin H ^a   Anderson, Shoana ^a   Kirschner, Denise ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Genetic susceptibility; Incidence rate; Next generation operator; Prevalence; SIR mathematical model; Tuberculosis

Indexed keywords

BACTERIA; COMPUTER SIMULATION; DISEASES; GENES; MATHEMATICAL MODELS;

DEMOGRAPHIC FACTORS;

EPIDEMIOLOGY;

DISEASE PREVALENCE; EPIDEMIOLOGY; MEDICAL GEOGRAPHY; TUBERCULOSIS;

DISEASE TRANSMISSION; EPIDEMIC; GENETIC SUSCEPTIBILITY; HUMAN; INCIDENCE; INDIA; MATHEMATICAL MODEL; POPULATION MODEL; PREVALENCE; REVIEW; TUBERCULOSIS; UNITED STATES;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0036845362     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(02)00133-5     Document Type: Article

References (81)

1. D. Snider Jr., M. Raviglione, A. Kochi, in: B. Bloom (Ed.), Global Burden of Tuberculosis, vol. 16, 1994, p. 3.
2. L. Reichman, J.H. Tanne, Timebomb: The Global Epidemic of Multi-drug-resistant Tuberculosis, McGraw-Hill, New York, NY, 2002.
3. P. Small, P. Hopewell, S. Singh, A. Paz, J. Parsonnet, D. Ruston, G. Schecter, C. Daley, G. Schoolnik, The epidemiology of tuberculosis in San Francisco - A population-based study using conventional and molecular methods, New Engl. J. Med. 330 (24) (1994) 1703.
4. D. Enarson, J. Murray, in: W. Rom, Garay (Eds.), Global Epidemiology of Tuberculosis, vol. 17, 1996, p. 57.
5. L. Wilson, The historical decline of tuberculosis in Europe and America, J. Hist. Med. Allied Sci. 45 (1990) 366.
6. K. Styblo, J. Meijer, I. Sutherland, The transmission of tuberculosis bacilli: Its trend in a human population, Bull. Int. Union Tuberc. 42 (1969) 5.
7. T. Daniel, J. Bates, K. Downes, in: B. Bloom (Ed.), History of Tuberculosis, vol. 16, 1994, p. 13.
8. D. Bleed, C. Watt, C. Dye, World Health Report 2001: Global Tuberculosis Control, Technical Report, World Health Organization, WHO/CDS/TB/2001.287, 2001. Available from 〈http://www.who.int/gtb/publications/globrep01/index.html〉.
9. CDC, Surveillance Reports: Reported Tuberculosis in the United States, 1999, Technical Report, Centers for Disease Control and Prevention, National Center for HIV, STD and TB Prevention, Division of Tuberculosis Elimination, 1999. Available from 〈http://www.cdc.gov/nchstp/tb/surv/surv99/surv99.htm〉.
10. A. Chakraborty, Prevalence and Incidence of Tuberculosis Infection and Disease in India: A Comprehensive Review, Technical Report, World Health Organization, 1997. WHO/TB/97.231.
11. WHO, World Health Report on the Tuberculosis Epidemic 1997, Technical Report, World Health Organization, 1997. Available from 〈http://www.who.int/gtb/publications/tbrep_97/〉.
12. P. Smith, A. Moss, in: B. Bloom (Ed.), Epidemiology of Tuberculosis, vol. 16, 1994, p. 47.
13. J. Plorde, Mycobacteria, in: K. Ryan, J. Sherris (Eds.), Sherris Medical Microbiolgy, An Introduction to Infectious Diseases, Appleton and Lange, 1994, p. 401.
14. J. Adler, D. Rose, in: W. Rom, Garay (Eds.), Transmission and Pathogenesis of Tuberculosis, vol. 17, 1996.
15. C. Karus, Tuberculosis: An overview of pathogenesis and prevention, Nurse Pract. 8 (2) (1983) 21.
16. B. Bloom (Ed.), Tuberculosis: Pathogenesis Protection and Control, ASM, Washington, BC, 1994.
17. W. Rom, S. Garay (Eds.), Tuberculosis, Little Brown, New York, 1996.
18. J. Chapman, M. Dyerly, Social and other factors in intrafamilial transmission of tuberculosis, Am. Rev. Respirat. Dis. 90 (1964) 48.
19. E. Nardell, W. Piessens, Transmission of tuberculosis, in: L. Reichman, E. Hershfield (Eds.), Tuberculosis: A Comprehensive International Approach, vol. 134, Macrel Dekker, New York, NY, 2000, p. 215.
20. D. Enarson, Why not the elimination of tuberculosis?, Mayo Clin. Proc. 69 (1994) 85.
21. G. Comstock, Epidemiology of tuberculosis, Am. Rev. Respirat. Dis. 125 (1982) 8.
22. K. Styblo, Tuberculosis control and surveillance, in: D. Flenley, T. Petty (Eds.), Recent Advances in Respiratory Medicine, vol. 4, Churchill, London, 1986, p. 77.
23. E. Vynnycky, P. Fine, The natural history of tuberculosis: The implications of age-dependent risks of disease and the role of reinfection, Epidemiol. Infect. 119 (1997) 183.
24. N. Parrish, J. Dick, P. Dolin, V. Pathania, M. Raviglione, Mechanisms of latency in Mycobacterium tuberculosis, Trends Microbiol. 6 (3) (1998) 107.
25. I. Kramnik, W. Dietrich, P. Demant, B. Bloom, Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis, PNAS 97 (15) (2000) 8560.
26. G. Bothamley, G. Schreuder, R. de Vries, J. Ivanyi, Association of antibody responses to the 19-kDa antigen of Mycobacterium tuberculosis and the HLA-DQ locus, J. Infect. Dis. 167 (4) (1993) 992.
27. A. Goldfeld, J. Delgado, S. Thim, M. Bozon, A. Uglialoro, D. Turbay, C. Cohen, E. Yunis, Association of an HLA-DQ allele with clinical tuberculosis, JAMA 279 (3) (1998) 26.
28. P. Selvaraj, H. Uma, A. Reetha, S. Kurian, HLA antigen profile in pulmonary tuberculosis patients and their spouses, Ind. J. Med. Res. 107 (1998) 155.
29. R. Bellamy, A. Hill, Genetic susceptibility to mycobacteria and other infectious pathogens in humans, Curr. Opinion Immunol. 10 (1998) 483.
30. R. Bellamy, C. Ruwende, T. Corrah, K. McAdam, H. Whittle, A. Hill, Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans, New Engl. J. Med. 338 (1998) 640.
31. R. Wilkinson, P. Patel, M. Llewelyn, C. Hirsch, G. Pasvol, G. Snounou, R. Davidson, Z. Toossi, Influence of polymorphisms in the genes for the interleukin IL-1 receptor agonist and IL-1/3rbeta on tuberculosis, J. Exp. Med. 189 (12) (1999) 1863.
32. A. Hill, The immunogenetics of human infectious diseases, Ann. Rev. Immunol. 16 (1998) 593.
33. A. Zachary, A. Steinberg, W. Bias, M. Leffell, The frequencies of HLA alleles and haplotypes and their distribution among donors and renal patients in the UNOS registry, Transplantation 62 (2) (1996) 272.
34. K. Pile, Broadsheet number 51: HLA and disease associations, Pathology 31 (1999) 202.
35. C. Meyer, J. May, K. Stark, Human leukocyte antigens in tuberculosis and leprosy, Trends Microbiol. 6 (4) (1998) 148.
36. T. Lim, Human genetic susceptibility to tuberculosis, Ann. Acad. Med. Singapore 29 (2000) 298.
37. H. Vordermeier, T-cell recognition of mycobacterial antigens, Europe. Respirat. J. 20 (1995) 657S.
38. R. Selby, J. Barnard, S. Buchler, J. Crumley, B. Larsem, W. Marshal, Tuberculosis association with HLA-B8 BfS in a Newfoundland community study, Tissue Antigens 11 (1978) 403.
39. L. Al-Arif, R. Goldstein, L. Affronti, B. Janicki, HLA-BW15 and tuberculosis in North American Black population, Am. Rev. Respirat. Dis. 120 (1979) 1275.
40. R. Cox, D. Arnold, D. Cook, D. Lundberg, HLA phenotypes in Mexican Americans with tuberculosis, Am. Rev. Respirat. Dis. 126 (1982) 653.
41. Z. Jiang, J. An, Y. Sun, K. Mittal, T. Lee, Association of HLA-BW35 with tuberculosis in the chinese, Tissue Antigens 22 (1983) 86.
42. L. Teran, M. Selman, M. Mendoza, H. Rubio, J. Banales, J. Granados, Increase in unidentified HLA antigens in pulmonary tuberculosis, Ann. Clin. Res. 17 (1985) 40.
43. A. Khomenko, V. Litvinov, V. Chukanova, L. Pospelov, Tuberculosis in patients with various HLA phenotypes, Tubercle 71 (1990) 187.
44. S. Singh, N. Mehra, H. Dingley, J. Pande, M. Vaidya, Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types, J. Infect. Dis. 148 (1983) 676.
45. G. Bothamley, J. Beck, G. Schreuder, J. D'Amaro, R. deVries, T. Kardjito, J. Ivanyi, Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA, J. Infect. Dis. 159 (1989) 549.
46. S. Brahmajothi, P. Vn, M. Kakkanaiah, K. Rajaram, S. Ramu, K. Palanimurugan, C. Paramasivan, R. Prabhakar, Association of pulmonary tuberculosis and HLA in South India, Tubercle 72 (1991) 123.
47. R. Rajalingam, N. Mehra, R. Jain, V. Myneedu, J. Pande, Polymerase chain reaction-based sequence-specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary Tuberculosis: Relevance to chemotherapy and disease severity, J. Infect. Dis. 173 (1996) 669.
48. K. Tracey, Tumor Necrosis Factor, Marcel Dekker, 1997, p. 223.
49. J. Flynn, J. Chan, Immunology of tuberculosis, Ann. Rev. Immunol. 19 (2001) 93.
50. A. Sullivan, J. Wigginton, D. Kirschner, The coreceptor mutation CCR5A32 influences the dynamics of HIV epidemics and is selected for by HIV, PNAS 18 (2001) 10214.
51. M. Behr, S. Warren, H. Salamon, P. Hopewell, A. deLeon, C. Daley, P. Small, Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli, Lancet 353 (9151) (1999) 444.
52. K. Sepkowitz, How contagious is tuberculosis?, Clin. Infect. Dis. 23 (1996) 954.
53. P. Fine, P. Small, Exogenous reinfection in tuberculosis, New Engl. J. Med. 341 (1999) 1226.
54. H. Hethcote, The mathematics of infectious diseases, SIAM Rev. 42 (4) (2000) 599.
55. F. Brauer, C. Castillo-Chávez, Mathematical Models in Population Biology and Epidemiology Texts in Applied Mathematics, Springer, New York, NY, 2001.
56. H. Hethcote, Qualitative analysis of communicable disease models, Math. Biosci. 28 (1976) 335.
57. S. Wolfram, Mathematica: A System for Doing Mathematics by Computer, Addison-Wesley, 1988.
58. H. Hethcote, J. Yorke, Gonorrhea transmission dynamics and control, Lecture Notes in Biomathematics, vol. 56, Springer, Heidelberg, 1984.
59. S. Blower, P. Small, P. Hopewell, Control strategies for tuberculosis epidemics: New models for old problems, Science 273 (1996) 497.
60. 0 in models for infectious diseases in heterogenous populations, J. Math. Biol. 28 (1990) 365.
61. P. van den Driessche, J. Watmough, Reproduction Numbers and Sub-Threshold Endemic Equilibria for Compartmental Models of Disease Transmission, 180 (2002) in press.
62. S. Blower, A. McLean, T. Porco, P. Small, P. Hopewell, M. Sanchez, A. Moss, The intrinsic transmission dynamics of tuberculosis epidemics, Nature Med. 1 (8) (1995) 815.
63. M. Sanchez, S. Blower, Uncertainty and sensitivity analysis of the basic reproductive rate, Am. J. Epidemiol. 145 (1997) 1127.
64. R. Iman, J. Helton, J. Campbell, An approach to sensitivity analysis of computer models: Part I - Introduction input variable selection and preliminary assessment, J. Qual. Technol. 13 (1981) 174.
65. R. Iman, J. Helton, J. Campbell, An approach to sensitivity analysis of computer models: Part II - Ranking of input variables response surface validation distribution effect and technique synopsis, J. Qual. Technol. 13 (1981) 232.
66. S. Blower, H. Dowlatabadi, Sensitivity and uncertainty analysis of complex models of disease transmission: An HIV model as an example, Int. Stat. Rev. 62 (2) (1994) 229.
67. V. Subramanian, P. Selvaraj, P. Narayanan, R. Prabhakar, C. Damodaran, Distribution of HLA (class I and II) antigens in the native Dravidian Hindus of Tamil Nadu, South India, Gene Geography 9 (1995) 15.
68. N. Mehra, V. Taneja, S. Kailash, N. Raizada, M. Vaidya, Distribution of HLA antigens in a sample of the North Indian Hindu population, Tissue Antigens 27 (1986) 64.
69. J. Awad, C. Navarrete, H. Festenstein, Frequency and associations of HLA-DR2 and HLA-DQ antigens in a British Caucasoid panel, Tissue Antigens 29 (1987) 55.
70. R. May, R. Anderson, Epidemiology and genetics in the coevolution of parasites and hosts, Proc. Roy. Soc. Lond. B 219 (1983) 281.
71. I.J. Longini, Models of epidemics and endemicity in genetically variable host populations, J. Mathemat. Biol. 17 (1983) 289.
72. J. Kemper, The evolutionary effect of endemic infectious disease: Continuous models for an invarient pathogen, J. Math. Biol. 15 (1982) 65.
73. J. Aparicio, A. Capurro, C. Castillo-Chávez, Markers of disease evolution: The case of tuberculosis, J. Theor. Biol. 215 (2) (2002) 227.
74. B. Murphy, B. Singer, D. Kirschner, Comparing Treatment Strategies of Tuberculosis in Demographically Distinct Heterogeneous Populations, submitted.
75. S. Papiha, J. Wentzel, F. Behjati, S. Agarwal, Human leukocyte antigens and circulating immunoglobulin levels in Indian patients with pulmonary tuberculosis, Tubercle 66 (1985) 25.
76. N. Mehra, K. Singhal, A. Malaviya, J. Guleria, M. Vaidaya, Susceptibility to tuberculosis may be HLA-linked, in: Proceedings of the Symposium of Cellular and Humoral Mechanisms on Cellular and Humoral Mechanisms in Immune Response, Bhabha Atomic Research Center, Bombay, India, 1982, p. 60.
77. WHO, World Health Report 1999: Making a Difference, Technical Report, World Health Organization, 1999. Available from 〈http://www.who.int/whr/1999/en/report.htm〉.
78. T. McDevitt, World Population Profile: 1998. Washington, DC: U.S. Government Printing Office, 1999. Available from 〈http://www.overpopulation.com〉.
79. A. Pablos-Mendez, T. Sterling, T. Frieden, The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis, JAMA 276 (15) (1996) 1223.
80. C.J. Murray, J. Salomon, Modeling the impact of global tuberculosis control strategies, PNAS 95 (1998) 13881.
81. International Cooperation in Health and Development, AIDS and Africa: Tuberculosis Prevention, Technical Report, Centre for International Cooperation in Health and Development, 2000. Available from 〈http:// www.ccisd.org/sidafrique/a_S.A1_2_2_SFETB.htm〉.